ESCMID 2025 vs HIV PEP Pro
Price, ratings, monetisation and update history for both apps, side by side β with what reviewers say about each.
ESCMID 2025
Read full descriptionHide full description
This is the official app of the 35th ESCMID Global congress (formerly ECCMID), which will take place in Vienna, Austria, from 11 - 15 April 2025. Leading experts will come together to discuss the latest developments in infectious diseases, infection control and clinical microbiology. Engage in a cutting-edge medical congress, while experiencing the city's irresistible charm. Vienna offers the perfect fusion of knowledge and adventure. With the app you will have access to the scientific programme, floorplans, abstracts and networking opportunities.
HIV PEP Pro
Read full descriptionHide full description
HIV PEP Pro is a clinical decision-support application designed to assist healthcare professionals in the assessment and management of HIV Post-Exposure Prophylaxis (PEP) based on Centers for Disease Control and Prevention (CDC) guidelines. The app follows a structured, step-by-step workflow aligned with current CDC recommendations for evaluating exposure risk, timing (72 hours), source HIV status, and patient-specific clinical factors. Key Features: β’ CDC guidelineβbased HIV PEP eligibility assessment β’ Time-dependent risk evaluation consistent with CDC exposure windows β’ Exposure-specific risk stratification following CDC definitions β’ Integrated CDC-aligned recommendations for: β HIV PEP β Sexually transmitted infection (STI) prophylaxis β Hepatitis B post-exposure management β Emergency contraception (when applicable) β’ Clear clinical summaries for point-of-care use β’ PDF export suitable for medical documentation β’ Designed for Emergency Medicine, Occupational Health, and Acute Care settings Intended Use: HIV PEP Pro is intended for use by licensed healthcare professionals only as a clinical decision-support tool based on CDC guidelines. It does not replace clinical judgment, institutional protocols, or specialist consultation. Disclaimer: This application provides guideline-based decision support and does not provide a medical diagnosis or treatment. Final clinical decisions must be made by the treating clinician in accordance with local policies and the latest CDC guidance.
Screenshots
Verdict
The clearest difference is price: ESCMID 2025 at Free against HIV PEP Pro's $1.99. ESCMID 2025 also leads on iOS requirement (14.0 vs 26.0). HIV PEP Pro's advantage is update cadence (weekly vs fortnightly). On ads, in-app purchases and device support there is nothing between them.
Scored on Price Β· Rating Β· Positive reviews Β· Number of ratings Β· Update frequency Β· Ads Β· In-app purchases Β· Monetization Β· Best chart rank Β· Devices Β· Requires iOS
ESCMID 2025 is free to download; HIV PEP Pro costs $1.99 up front. Neither carries in-app purchases, so what you see is what you pay.
ESCMID 2025 ships an update fortnightly, HIV PEP Pro weekly. The most recent releases landed on September 22, 2026 and November 9, 2026 respectively.
| Parameter | ESCMID 2025 | HIV PEP Pro |
|---|---|---|
| Price | Free β better | $1.99 |
| Update frequency | Fortnightly | Weekly β better |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPad, iPod β better | iPhone, iPad |
| Requires iOS | 14.0 β better | 26.0 |
| Further details β not scored | ||
| Size | 88 MB | 17 MB |
| Age rating | 17+ | 4+ |
| Developer | key4events | Mohammed Rashid |
In-app purchases
ESCMID 2025
No in-app purchases
HIV PEP Pro
No in-app purchases









